http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104961808-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104961808-B |
| titleOfInvention | It is used to prepare the polypeptide and its preparation method and application of the O-shaped peptide vaccine of ox aftosa |
| abstract | The present invention provides a kind of polypeptide being used to prepare the O-shaped peptide vaccine of ox aftosa, and the polypeptide includes the amino acid sequence as shown in SEQ ID NO.1 and contains the peptide vaccine of the polypeptide.The O-shaped synthetic peptide vaccine of ox aftosa of offer has good immune efficacy, and the problems such as existing fever of traditional vaccine, redness will not be caused, therefore the vaccine of the present invention can successfully manage the antigenic variation of current foot and mouth disease virus, biological safety is not present, it is easy to synthesize on a large scale, has a good application prospect.The present invention also provides the preparation methods and its pharmaceutical applications of the polypeptide and peptide vaccine. |
| priorityDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.